U.S. Subpoena Opens a New Front in Investigation ofGuidant Heart Devices
"The subpoena shows that the government is investigating Guidant for possible violations of health care statutes
"The subpoena shows that the government is investigating Guidant for possible violations of health care statutes
"Now they are terrified that their crimes of commission and omission could reap them the same whirlwind harvest of accountability."
We are, however, very distressed at what appears to us to be a significant discrepancy between your statements and the reality of SAMHSA’s role in implementing the NFC report recommendations, as well as other discrepancies between your statements and SAMHSA’s actions.
"It’s not a question of just knowing the risks and it’s not a question of labeling against risk. The question is how do you change behavior?"
Your average car would cost $4.5 million, representing a 30,000% markup over cost, which is typical for prescription drugs.
Pharmaceutical News reports that the FDA has issued warnings about diet pills from Brazil marketed as dietary supplements, that contain Prozac and Librium.
This issue is NOT about trial lawyers, this issue is about the rights and health, and safety of ordinary citizens.
In what appears to be a re-run of the Katrina rescue disaster–The New York Times front page report provides yet another example of mindless and heartless shot gun public polices that are being tested on a vulnerable population of citizens:
Two items in today’s New York Times illustrate the contrast between what the Administration claims it’s legislative / regulatory proposals will do for health care, and what they actually do after they’ve taken effect.
Big Pharma by Jacky Law reveals that in essence, most of the pharmaceutical industry’s claims are false; it is not the drug, but the placebo effect whose potency deserves almost all of the credit for any health improvement:
FDA political appointees have embarked on a plan to divest the American consumer of the right to seek compensation for defective prescription drugs.
The Senate Finance committee is cracking down on drug industry "educational grants" to physicians, medical associations and "patient advocacy" groups.